These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9916327)
1. Artificial neural network classification based on capillary electrophoresis of urinary nucleosides for the clinical diagnosis of tumors. Zhao R; Xu G; Yue B; Liebich HM; Zhang Y J Chromatogr A; 1998 Dec; 828(1-2):489-96. PubMed ID: 9916327 [TBL] [Abstract][Full Text] [Related]
2. Artificial neural network classification based on high-performance liquid chromatography of urinary and serum nucleosides for the clinical diagnosis of cancer. Yang J; Xu G; Kong H; Zheng Y; Pang T; Yang Q J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(1):27-33. PubMed ID: 12383477 [TBL] [Abstract][Full Text] [Related]
3. Multilayer perceptron tumour diagnosis based on chromatography analysis of urinary nucleosides. Seidel P; Seidel A; Herbarth O Neural Netw; 2007 Jul; 20(5):646-51. PubMed ID: 17275256 [TBL] [Abstract][Full Text] [Related]
4. Application of capillary electrophoresis in clinical chemistry: the clinical value of urinary modified nucleosides. Liebich HM; Lehmann R; Xu G; Wahl HG; Häring HU J Chromatogr B Biomed Sci Appl; 2000 Aug; 745(1):189-96. PubMed ID: 10997714 [TBL] [Abstract][Full Text] [Related]
5. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients. Liebich HM; Xu G; Di Stefano C; Lehmann R J Chromatogr A; 1998 Jan; 793(2):341-7. PubMed ID: 9474787 [TBL] [Abstract][Full Text] [Related]
7. Chromatographic, capillary electrophoretic and matrix-assisted laser desorption ionization time-of-flight mass spectrometry analysis of urinary modified nucleosides as tumor markers. Liebich HM; Müller-Hagedorn S; Klaus F; Meziane K; Kim KR; Frickenschmidt A; Kammerer B J Chromatogr A; 2005 Apr; 1071(1-2):271-5. PubMed ID: 15865203 [TBL] [Abstract][Full Text] [Related]
8. Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from uterine myoma and cervical cancer patients. Kim KR; La S; Kim A; Kim JH; Liebich HM J Chromatogr B Biomed Sci Appl; 2001 Apr; 754(1):97-106. PubMed ID: 11318432 [TBL] [Abstract][Full Text] [Related]
9. Modified nucleosides as biomarkers for early cancer diagnose in exposed populations. Seidel A; Seidel P; Manuwald O; Herbarth O Environ Toxicol; 2015 Jul; 30(8):956-67. PubMed ID: 24615900 [TBL] [Abstract][Full Text] [Related]
10. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patients. Xu G; Liebich HM; Lehmann R; Müller-Hagedorn S Methods Mol Biol; 2001; 162():459-74. PubMed ID: 11217356 [No Abstract] [Full Text] [Related]
11. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography. Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266 [TBL] [Abstract][Full Text] [Related]
12. Modified nucleosides: an accurate tumour marker for clinical diagnosis of cancer, early detection and therapy control. Seidel A; Brunner S; Seidel P; Fritz GI; Herbarth O Br J Cancer; 2006 Jun; 94(11):1726-33. PubMed ID: 16685264 [TBL] [Abstract][Full Text] [Related]
13. Two approaches for determining the urinary excretion patterns of nucleosides--HPLC and CE. Xu G; Lu X; Zhang Y; Lu P; Di Stefano C; Lehmann R; Liebich H Se Pu; 1999 Mar; 17(2):97-101. PubMed ID: 12549143 [TBL] [Abstract][Full Text] [Related]
14. Urinary nucleosides as biomarkers of breast, colon, lung, and gastric cancer in Taiwanese. Hsu WY; Chen CJ; Huang YC; Tsai FJ; Jeng LB; Lai CC PLoS One; 2013; 8(12):e81701. PubMed ID: 24367489 [TBL] [Abstract][Full Text] [Related]
15. Capillary electrophoresis-mass spectrometry for direct determination of urinary modified nucleosides. Evaluation of synthetic urine as a surrogate matrix for quantitative analysis. Rodríguez-Gonzalo E; Hernández-Prieto R; García-Gómez D; Carabias-Martínez R J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 942-943():21-30. PubMed ID: 24212140 [TBL] [Abstract][Full Text] [Related]
16. A noninvasive cancer detection strategy based on gold nanoparticle surface-enhanced raman spectroscopy of urinary modified nucleosides isolated by affinity chromatography. Feng S; Zheng Z; Xu Y; Lin J; Chen G; Weng C; Lin D; Qiu S; Cheng M; Huang Z; Wang L; Chen R; Xie S; Zeng H Biosens Bioelectron; 2017 May; 91():616-622. PubMed ID: 28103517 [TBL] [Abstract][Full Text] [Related]
17. Assessment of nucleosides as putative tumor biomarkers in prostate cancer screening by CE-UV. Buzatto AZ; de Oliveira Silva M; Poppi RJ; Simionato AVC Anal Bioanal Chem; 2017 May; 409(13):3289-3297. PubMed ID: 28343345 [TBL] [Abstract][Full Text] [Related]
18. Novel approach for developing urinary nucleosides profile by capillary electrophoresis-mass spectrometry. Wang S; Zhao X; Mao Y; Cheng Y J Chromatogr A; 2007 Apr; 1147(2):254-60. PubMed ID: 17336316 [TBL] [Abstract][Full Text] [Related]
19. Prediction of electrophoretic mobilities of alkyl- and alkenylpyridines in capillary electrophoresis using artificial neural networks. Jalali-Heravi M; Garkani-Nejad Z J Chromatogr A; 2002 Sep; 971(1-2):207-15. PubMed ID: 12350116 [TBL] [Abstract][Full Text] [Related]
20. Urinary nucleosides as biological markers for patients with colorectal cancer. Zheng YF; Yang J; Zhao XJ; Feng B; Kong HW; Chen YJ; Lv S; Zheng MH; Xu GW World J Gastroenterol; 2005 Jul; 11(25):3871-6. PubMed ID: 15991285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]